d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A Phase II Multi-center, Open Label, Randomized Study to Assess Safety and Efficacy of Two Different Schedules of Oral LDE225 in Adult Patients With Relapsed/Refractory or Untreated Elderly Patients With Acute Leukemia [Country] NO [Cancer type] 
Leukemia
Nordic NECT - Inclusion completed
Cancer type